NY S04370 | 2021-2022 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 13-0)
Status: Introduced on February 3 2021 - 25% progression, died in committee
Action: 2022-06-03 - COMMITTED TO RULES
Pending: Senate Rules Committee
Text: Latest bill text (Amended) [HTML]

Summary

Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.

Sponsors


History

DateChamberAction
2022-06-03SenateCOMMITTED TO RULES
2022-05-17SenateADVANCED TO THIRD READING
2022-05-16Senate2ND REPORT CAL.
2022-05-11Senate1ST REPORT CAL.1331
2022-05-05SenatePRINT NUMBER 4370B
2022-05-05SenateAMEND AND RECOMMIT TO HEALTH
2022-05-02SenatePRINT NUMBER 4370A
2022-05-02SenateAMEND AND RECOMMIT TO HEALTH
2022-01-05SenateREFERRED TO HEALTH
2021-02-03SenateREFERRED TO HEALTH

Same As/Similar To

A07245 (Same As) 2022-05-23 - print number 7245a

New York State Sources


Bill Comments

feedback